Somalogic Performance

The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Somalogic are completely uncorrelated.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Somalogic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Somalogic is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Begin Period Cash Flow440.3 M
Total Cashflows From Investing Activities82.5 M
  

Somalogic Relative Risk vs. Return Landscape

If you would invest (100.00) in Somalogic on November 27, 2024 and sell it today you would earn a total of  100.00  from holding Somalogic or generate -100.0% return on investment over 90 days. Somalogic is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Somalogic, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketSLGC 0.00.10.20.30.40.50.60.70.8 -0.04-0.03-0.02-0.010.000.01
       Risk  

Somalogic Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Somalogic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Somalogic, and traders can use it to determine the average amount a Somalogic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
SLGC
Based on monthly moving average Somalogic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Somalogic by adding Somalogic to a well-diversified portfolio.

Somalogic Fundamentals Growth

Somalogic Stock prices reflect investors' perceptions of the future prospects and financial health of Somalogic, and Somalogic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Somalogic Stock performance.

Things to note about Somalogic performance evaluation

Checking the ongoing alerts about Somalogic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Somalogic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Somalogic is not yet fully synchronised with the market data
Somalogic has some characteristics of a very speculative penny stock
Somalogic has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 97.67 M. Net Loss for the year was (109.16 M) with loss before overhead, payroll, taxes, and interest of (11.27 M).
Somalogic currently holds about 566.34 M in cash with (100.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.02.
Roughly 62.0% of the company shares are owned by institutional investors
Evaluating Somalogic's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Somalogic's stock performance include:
  • Analyzing Somalogic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Somalogic's stock is overvalued or undervalued compared to its peers.
  • Examining Somalogic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Somalogic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Somalogic's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Somalogic's stock. These opinions can provide insight into Somalogic's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Somalogic's stock performance is not an exact science, and many factors can impact Somalogic's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Somalogic Stock

If you are still planning to invest in Somalogic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Somalogic's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance

Trending Assets

HCAT
Health Catalyst
4.95  -0.28  -5.35 
PGNY
Progyny
22.98  -0.22  -0.95 
RCM
R1 RCM Inc
0.00  0.00  0.00 
DH
Definitive Healthcare
4.97  0.05  1.02